{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:29:59Z","timestamp":1789000199460,"version":"build-2803163510"},"reference-count":32,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T00:00:00Z","timestamp":1770249600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003030","name":"Generalitat de Catalunya Ag\u00e8ncia de Gesti\u00f3 d'Ajuts Universitaris i de Recerca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008054","name":"Fundacion Ramon Areces","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI23\/00692"],"award-info":[{"award-number":["PI23\/00692"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI18\/01077"],"award-info":[{"award-number":["PI18\/01077"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002809","name":"Generalitat de Catalunya","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jidonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.jid.2026.01.030","type":"journal-article","created":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T00:26:33Z","timestamp":1770423993000},"page":"2232-2241.e6","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Exploring global cfDNA fragmentomics as a biomarker in real-world patients with melanoma"],"prefix":"10.1016","volume":"146","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1821-8836","authenticated-orcid":false,"given":"Daniel","family":"Rizo-Potau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-7053-8044","authenticated-orcid":false,"given":"Anton","family":"Forni\u00e9s-Marin\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7445-1267","authenticated-orcid":false,"given":"Jos\u00e9 Luis","family":"Villanueva-Ca\u00f1as","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Aguilar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"S\u00e1nchez-C\u00e1rdenas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3847-2647","authenticated-orcid":false,"given":"Teresa","family":"Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4150-0522","authenticated-orcid":false,"given":"Sebastian","family":"Podlipnik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1608-8820","authenticated-orcid":false,"given":"Cristina","family":"Carrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1337-9745","authenticated-orcid":false,"given":"Susana","family":"Puig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6998-914X","authenticated-orcid":false,"given":"Josep","family":"Malvehy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4345-9631","authenticated-orcid":false,"given":"Joan Anton","family":"Puig-Butill\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jid.2026.01.030_bib3","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1186\/s13550-024-01170-x","article-title":"cfDNA fragmentation patterns correlate with tumor burden measured via PSMA PET\/CT volumetric parameters in patients with biochemical recurrence of prostate cancer","volume":"14","author":"Amseian","year":"2024","journal-title":"EJNMMI Res"},{"key":"10.1016\/j.jid.2026.01.030_bib4","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s12943-022-01594-w","article-title":"Letter to the editor: an ultra-sensitive assay using cell-free DNA fragmentomics for multi-cancer early detection","volume":"21","author":"Bao","year":"2022","journal-title":"Mol Cancer"},{"key":"10.1016\/j.jid.2026.01.030_bib5","article-title":"Exploring circulating tumor DNA (CtDNA) and its role in early detection of cancer: a systematic review","volume":"15","author":"Bittla","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.jid.2026.01.030_bib6","doi-asserted-by":"crossref","first-page":"3286","DOI":"10.1158\/0008-5472.CAN-23-3486","article-title":"Multidimensional fragmentomics enables early and accurate detection of colorectal cancer","volume":"84","author":"Cao","year":"2024","journal-title":"Cancer Res"},{"key":"10.1016\/j.jid.2026.01.030_bib8","article-title":"Plasma cell-free DNA integrity assessed by automated electrophoresis predicts the achievement of pathologic complete response to neoadjuvant chemotherapy in patients with breast cancer","volume":"6","author":"Cirmena","year":"2022","journal-title":"JCO Precis Oncol"},{"key":"10.1016\/j.jid.2026.01.030_bib9","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/s41586-019-1272-6","article-title":"Genome-wide cell-free DNA fragmentation in patients with cancer","volume":"570","author":"Cristiano","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.jid.2026.01.030_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2021.101072","article-title":"The prognostic value of circulating tumor DNA in patients with melanoma: a systematic review and meta-analysis","volume":"14","author":"Feng","year":"2021","journal-title":"Transl Oncol"},{"key":"10.1016\/j.jid.2026.01.030_bib11","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.3390\/diagnostics14202293","article-title":"Role of liquid biopsy in progressive PSA patients after radical prostatectomy","volume":"14","author":"Figueras","year":"2024","journal-title":"Diagnostics (Basel)"},{"key":"10.1016\/j.jid.2026.01.030_bib12","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.ejca.2022.04.018","article-title":"European consensus-based interdisciplinary guideline for melanoma. Part 2: treatment - update 2022","volume":"170","author":"Garbe","year":"2022","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jid.2026.01.030_bib13","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232214197","article-title":"Cell-free DNA fragmentomics: a promising biomarker for diagnosis, prognosis and prediction of response in breast cancer","volume":"23","author":"Gianni","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jid.2026.01.030_bib14","doi-asserted-by":"crossref","first-page":"3631","DOI":"10.1007\/s00259-021-05306-2","article-title":"Cell-free DNA concentration and fragment size fraction correlate with FDG PET\/CT-derived parameters in NSCLC patients","volume":"48","author":"Gonz\u00e1lez de Aledo-Castillo","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.jid.2026.01.030_bib15","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1146\/annurev-med-100223-090016","article-title":"Circulating tumor DNA: a pan-cancer biomarker in solid tumors with prognostic and predictive value","volume":"76","author":"Hitchen","year":"2025","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.jid.2026.01.030_bib16","doi-asserted-by":"crossref","DOI":"10.4028\/b-7TThNX","article-title":"Systematically evaluating cell-free DNA fragmentation patterns for cancer diagnosis and enhanced cancer detection via integrating multiple fragmentation patterns","volume":"11","author":"Hou","year":"2024","journal-title":"Adv Sci (Weinh)"},{"key":"10.1016\/j.jid.2026.01.030_bib17","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1186\/1471-2164-16-S13-S1","article-title":"Non-random fragmentation patterns in circulating cell-free DNA reflect epigenetic regulation","volume":"16","author":"Ivanov","year":"2015","journal-title":"BMC Genomics"},{"key":"10.1016\/j.jid.2026.01.030_bib18","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.772165","article-title":"Predictive performance of serum S100B versus LDH in melanoma patients: a systematic review and meta-analysis","volume":"11","author":"Janka","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.jid.2026.01.030_bib20","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1186\/s12967-018-1677-2","article-title":"Fragment size and level of cell-free DNA provide prognostic information in patients with advanced pancreatic cancer","volume":"16","author":"Lapin","year":"2018","journal-title":"J Transl Med"},{"key":"10.1016\/j.jid.2026.01.030_bib21","doi-asserted-by":"crossref","first-page":"5793","DOI":"10.1021\/ja100342q","article-title":"Decoding circulating nucleic acids in human serum using microfluidic single molecule spectroscopy","volume":"132","author":"Liu","year":"2010","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.jid.2026.01.030_bib22","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1373\/clinchem.2018.298323","article-title":"Guidelines for the preanalytical conditions for analyzing circulating cell-free DNA","volume":"65","author":"Meddeb","year":"2019","journal-title":"Clin Chem"},{"key":"10.1016\/j.jid.2026.01.030_bib24","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aat4921","article-title":"Enhanced detection of circulating tumor DNA by fragment size analysis","volume":"10","author":"Mouliere","year":"2018","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jid.2026.01.030_bib25","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1038\/nm.3519","article-title":"An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage","volume":"20","author":"Newman","year":"2014","journal-title":"Nat Med"},{"key":"10.1016\/j.jid.2026.01.030_bib26","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.annonc.2022.05.520","article-title":"ESMO recommendations on the use of circulating tumour DNA assays for patients with cancer: a report from the ESMO Precision Medicine Working Group","volume":"33","author":"Pascual","year":"2022","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jid.2026.01.030_bib27","doi-asserted-by":"crossref","first-page":"3396","DOI":"10.3390\/jcm9113396","article-title":"Incidence of melanoma in Catalonia, Spain, is rapidly increasing in the elderly population. A multicentric cohort study","volume":"9","author":"Podlipnik","year":"2020","journal-title":"J Clin Med"},{"key":"10.1016\/j.jid.2026.01.030_bib28","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1111\/bjd.16833","article-title":"Cost-effectiveness analysis of imaging strategy for an intensive follow-up of patients with American Joint Committee on Cancer stage IIB, IIC and III malignant melanoma","volume":"180","author":"Podlipnik","year":"2019","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2026.01.030_bib30","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.144561","article-title":"Circulating nuclear DNA structural features, origins, and complete size profile revealed by fragmentomics","volume":"6","author":"Sanchez","year":"2021","journal-title":"JCI Insight"},{"key":"10.1016\/j.jid.2026.01.030_bib31","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.943253","article-title":"Circulating tumor DNA as a cancer biomarker: an overview of biological features and factors that may impact on ctDNA analysis","volume":"12","author":"S\u00e1nchez-Herrero","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.jid.2026.01.030_bib32","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/s41698-024-00567-0","article-title":"A multiparameter liquid biopsy approach allows to track melanoma dynamics and identify early treatment resistance","volume":"8","author":"Scaini","year":"2024","journal-title":"NPJ Precis Oncol"},{"key":"10.1016\/j.jid.2026.01.030_bib33","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1093\/annonc\/mdz048","article-title":"Prediction and monitoring of relapse in stage III melanoma using circulating tumor DNA","volume":"30","author":"Tan","year":"2019","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jid.2026.01.030_bib35","article-title":"Circulating DNA fragmentomics and cancer screening","volume":"3","author":"Thierry","year":"2023","journal-title":"Cell Genom"},{"key":"10.1016\/j.jid.2026.01.030_bib36","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1080\/10408363.2020.1750558","article-title":"Preanalytical variables that affect the outcome of cell-free DNA measurements","volume":"57","author":"Ungerer","year":"2020","journal-title":"Crit Rev Clin Lab Sci"},{"key":"10.1016\/j.jid.2026.01.030_bib37","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1164\/rccm.202109-2019OC","article-title":"Multidimensional cell-free DNA fragmentomic assay for detection of early-stage lung cancer","volume":"207","author":"Wang","year":"2023","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jid.2026.01.030_bib38","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1016\/j.jid.2022.02.021","article-title":"Cell-free DNA in dermatology research","volume":"142","author":"Wiggins","year":"2022","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jid.2026.01.030_bib39","doi-asserted-by":"crossref","first-page":"20467","DOI":"10.18632\/oncotarget.24943","article-title":"Increased level and fragmentation of plasma circulating cell-free DNA are diagnostic and prognostic markers for renal cell carcinoma","volume":"9","author":"Yamamoto","year":"2018","journal-title":"Oncotarget"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X26000795?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X26000795?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T19:24:30Z","timestamp":1786735470000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X26000795"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":32,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S0022202X26000795"],"URL":"https:\/\/doi.org\/10.1016\/j.jid.2026.01.030","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploring global cfDNA fragmentomics as a biomarker in real-world patients with melanoma","name":"articletitle","label":"Article Title"},{"value":"Journal of Investigative Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jid.2026.01.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of Society for Investigative Dermatology.","name":"copyright","label":"Copyright"}]}}